Quarterly report pursuant to Section 13 or 15(d)

Note 1 - History and Basis of Presentation: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)

v2.4.0.6
Note 1 - History and Basis of Presentation: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2013
Tables/Schedules  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

 

 

 

March 31,

 2013

 

 

March 31,

 2012

 

 

 

 

Convertible notes

18,900,000

18,900,000

Convertible preferred stock - Series B

11,818,181

11,818,181

Warrants

24,585,662

10,507,214

Compensation-based stock options and warrants

69,208,483

65,036,263

 

124,512,326

106,261,658